• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

FDA grants full approval for Roche/AbbVie’s Venclexta in AML combination therapies

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Oct 19, 2020 at 11:12: AM
via Combination therapies involving Roche and AbbVie’s cancer drug Venclexta have been formally approved by the FDA in acute myeloid leukaemia, following supportive data from late-stage studies.

article source
 




Top Bottom
Back
Quote